# Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct01790997` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01790997](<https://clinicaltrials.gov/study/NCT01790997>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01790997

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

## Technical summary

Registry record NCT01790997. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 126 participants (enrolled count; ClinicalTrials.gov record NCT01790997, source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01790997, source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01790997, source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01790997, source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT01790997, source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01790997-2014-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): DLBS1033
- Intervention (Drug): Aspirin
- Intervention (Drug): Clopidogrel
- Lead sponsor: Dexa Medica Group
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: Dexa Medica Group (`cardio:org-dexa-medica-group`)

## Provenance

Content hash: 8687735adacdd786fd951f073a0df66694944f61323891a8a9f135fc58ecf1d1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
